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RegulationThe sodium-dependent multivitamin transporter (SMVT) is a major biotin transporter in a variety of tissues
including the small intestine. The human SMVT (hSMVT) polypeptide is predicted to have four N-
glycosylation sites and two putative PKC phosphorylation sites but their role in the function and regulation of
the protein is not known and was examined in this investigation. Our results showed that the hSMVT protein
is glycosylated and that this glycosylation is important for its function. Studies utilizing site-directed
mutagenesis revealed that the N-glycosylation sites at positions Asn138 and Asn489 are important for the
function of hSMVT and that mutating these sites signiﬁcantly reduces the Vmax of the biotin uptake process.
Mutating the putative PKC phosphorylation site Thr286 of hSMVT led to a signiﬁcant decrease in the PMA-
induced inhibition in biotin uptake. The latter effect was not mediated via changes in the level of expression of
the hSMVT protein and mRNA or in its level of expression at the cell membrane. These ﬁndings demonstrate
that the hSMVT protein is glycosylated, and that glycosylation is important for its function. Furthermore, the
study shows a role for the putative PKC-phosphorylation site Thr286 of hSMVT in the PKC-mediated regulation
of biotin uptake.ng Beach, CA 90822, USA. Tel.:
l rights reserved.© 2011 Elsevier B.V. All rights reserved.1. Introduction
Biotin, a water-soluble vitamin, is required for normal cellular
functions, growth and development. It acts as a coenzyme for ﬁve
carboxylases involved in a variety of intermediate metabolic reactions
that include fatty acid synthesis, gluconeogenesis, and catabolism of
branched chains amino acids [1]. The importance of biotin as an
essential micronutrient is underscored by the range of abnormalities
that develop as result of its deﬁciency which include growth
retardation, and neurological and dermatological disorder [2]. The
incidence of biotin deﬁciency and sub-optimal levels are common in
both developed and developing countries and occurs due to a variety
of factors and conditions.
Humans and other mammals cannot synthesize biotin and must
obtain the micronutrient from exogenous sources via intestinal
absorption. Two sources of biotin are available to the human intestine;
a dietary source, which is absorbed in the small intestine, and a
bacterial source where the vitamin is synthesized by the normal
microﬂora of the large intestine and is absorbed in that region of thegut [3–7]. Absorption of both sources of biotin occurs by a saturable,
Na+-dependent, carrier-mediated mechanism that involves the
sodium-dependent multivitamin transporter (SMVT) [8,9]. The
human SMVT (hSMVT) is the product of the SLC5A6 gene, which is
located on chromosome 2. Molecular identity of SMVT system has
been delineated as a result of cloning from a number of species
(human, rabbit, mice, rat) [10–12]. Hydrophobicity analysis predicts
the hSMVT protein to have 12 trans-membrane domains (TMD), and
that both the N- and C-termini are oriented toward the cell interior
[11]. The hSMVT protein has also been predicted to have four
potential N-glycosylation sites (at Asn138, Asn489, Asn498 and Asn534)
and two potential protein kinase C (PKC) phosphorylation sites
(Ser283 and Thr286) [11,13]. Functional, immunological and confocal
imaging studies from our laboratory and others have shown that the
hSMVT protein is exclusively expressed at the apical membrane
domain of polarized intestinal epithelial cells [8,9,14]. Other studies,
utilizing gene-speciﬁc siRNA approach, have shown that the hSMVT
system is themain biotin uptake system in human intestinal epithelial
cells [15]. Furthermore, modulators of the PKC-mediated regulatory
pathway were found to exert a signiﬁcant effect on intestinal biotin
uptake via changes in the number/activity of the biotin uptake carriers
with no effect on their afﬁnity [16,17].
There is little known about the structure–function and structure–
regulatory relationships of the hSMVT system. We have begun to
address these issues and have recently shown the importance of the
conserved positively charged His115 and His254 residues in the
Table 1
Combination of primers used for PCR.
Forward and reverse primers (5′–3′)
hSMVT-RT F TGTCTACCTTCTCCATCATGGA;
R TAGAGCCCAATGGCAAGAGA
β-actin F AAATGGGTTCTAGACCGCGGAGA;
R CATGCTCGATGCGGTACTTCA
N138A F CTGGAGCTTCGATTCGCTAAAACTGTGCGAGTG;
R CACTCGCACAGTTTTAGCGAATCGAAGCTCCAG
N489A F CCACCCTCTCCCTCTGCTGGGTCCAGCTTCTCC;
R GGAGAAGCTGGACCCAGCAGAGGGAGAGGGTGG
N498A F TTCTCCCTGCCCACCGCTCTAACCGTTGCCACT ;
R AGTGGCAACGGTTAGAGCGGTGGGCAGGGAGAA
N534A F TGGTACAGTGCTCACGCCTCCACCACAGTGATT;
R AATCACTGTGGTGGAGGCGTGAGCACTGTACCA
S283A F GTGCAGCGGTACCTCGCTTCCCGCACGGAGAAG;
R CTTCTCCGTGCGGGAAGCGAGGTACCGCTGCAC
T286A F TACCTCAGTTCCCGCGCGGAGAAGGCTGCTGTG;
R CACAGCAGCCTTCTCCGCGCGGGAACTGAGGTA
“hSMVT-RT” and β-actin denote the primer sequences used for quantitative real-time
RT-PCR. The changed nucleotides to mutate hSMVT are shown in bold in the respective
primer sequence.
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histidine residues results in changes in the membrane expression of
hSMVT [18]. More work is needed to fully understanding the
structure–function and structure–regulatory relationships of the
hSMVT system.
As mentioned earlier, the hSMVT polypeptide is predicted to have
four potential N-glycosylation sites but it is not known if these sites
are actually glycosylated, and what effect such glycosylation has on
the physiology of hSMVT. Also not known is whether any of the two
conserved putative PKC phosphorylation sites of hSMVT are involved
in mediating the PKC regulatory effect on biotin uptake observed in
our previous studies [16,17]. Our aim in this study was to address
these issues.
2. Materials and methods
2.1. Material
[3H] biotin (speciﬁc activityN30 Ci/mmol, radiochemical pu-
rityN98%) was obtained from American Radiolabeled Chemicals
(ARC, St. Louis, MO). All the other chemicals used in the study were
commercially obtained from the vendors and are of analytical/
molecular biology grade.
2.2. Cell culture and transfection
Human retinal pigmented epithelial cells (ARPE19; which are
highly efﬁcient in expressing hSMVT; [13]) and human intestinal
epithelial cell (Caco-2) were used for uptake and confocal imaging
studies. These cells were obtained from ATCC (Manassas, VA), and
were cultured in DMEM and MEM medium (Sigma, St. Louise, MO),
respectively, at 37 °C in a 5% CO2–95% air atmosphere. For optimized
growth, the culture mediumwas supplemented with 10% fetal bovine
serum and penicillin (100 units/ml) as well as streptomycin (100 μg/
ml). Transient transfection was performed using Lipofectamine 2000
(Invitrogen) following manufacturer's protocol.
2.3. Transport measurement
Radiolabeled biotin uptake was determined at 37 °C in Krebs–
Ringer (KR) buffer for initial linear period of 10 min as previously
described [17,18]. Protein concentrations of cell digest weremeasured
in parallel using Dc protein assay kit (Bio-Rad, Hercules, CA). Total
biotin uptake mediated by endogenous transporter was determined
using ARPE19 cell transfected with pcDNA 3.1(−) vector and carrier-
mediated biotin uptake was determined by subtracting the passive
diffusion component from total uptake.
2.4. Site-directed mutagenesis
For introducing mutations we used full-length hSMVT constructs
cloned either in pcDNA 3.1(−) [18] (Invitrogen) or GFP-N3
expression vector (Clontech, Mountain View, CA) [14]. Quick Change
II site-directed mutagenesis kit from Stratagen (La Jolla, CA) was used
for mutating individual residues using speciﬁc mutant primers
(Table 1). Brieﬂy, either hSMVT-pcDNA 3.1(−) or hSMVT-GFP
constructs were used as template and PCR was performed using
speciﬁc mutant primers following the manufacturer's instruction. The
mutated clone was identiﬁed by sequencing from the isolated plasmid
DNA (Laragen, CA).
2.5. Real-time PCR analysis
Total RNA was isolated after 48 h post transfection using TRizol
reagent (Invitrogen) as mentioned in the manufacturer's protocol. To
remove the residual DNA contamination RNA samples were treatedwith DNAse I (Invitrogen) and cDNAwas prepared using iScript cDNA
synthesis kit (Bio-Rad). The level of hSMVT expression was quantiﬁed
in CFX 96 real-time PCR system (Bio-Rad) using a speciﬁc primer [19]
and a corresponding β-actin expression was used for normalization.
The relative expression of hSMVT was quantiﬁed by a comparative CT
method (2−ΔΔCT method) where the ΔCT value was calculated by
subtracting the CT value of β-actin from hSMVT [20].
2.6. Total protein isolation and Western blotting
To measure the total expression of hSMVT protein, ARPE19 cells
(48 h post transfection) were lysed with RIPA buffer (Sigma)
supplemented with a protease inhibitor cocktail (Roche, NJ). An
equal amount of protein (30 μg) was electrophoresed in NuPAGE 4–
12% Bis–Tris gradient minigels (Invitrogen) and electro blotted onto a
nitrocellulose membrane (Amersham Biosciences, Piscataway, NJ) for
Western blot analysis as described before [18]. To detect a speciﬁc
protein, the blot was probed for 90 min with a speciﬁc antibody [anti-
human polyclonal SMVT antibodies (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA) or anti-GFP monoclonal antibody (Clontech)]
followed by a corresponding secondary antibody conjugated with
horseradish peroxidase for 1 h at room temperature and the bands
were developed by an enhanced chemiluminescence (ECL) kit
(Amersham Biosciences). To ensure the equal loading, the same blot
was stripedwith re-striping solution (Chemicon, CA) and probedwith
anti-human β-actin polyclonal antibodies (Santa Cruz biotechnology
Inc.). Intensity level of each band was determined and normalized
with human β-actin by UN-SCAN-IT gel software (version 6.1).
2.7. Cell surface biotinylation assay
Total surface protein of transiently transfected cells was biotiny-
lated using an EZ-Link Sulfo-NHS-Biotinylation Kit (Thermo Fisher
Scientiﬁc Inc., Rockford, IL) following the protocol described by the
manufacturer. Brieﬂy, after biotinylation the cells were lysed, and the
lysate was incubated with avidine-conjugated agarose. Followed by
washing the biotinylated protein was bound to an agarose–avidine
bead that was eluted in a NuPAGE LDS sample loading dye and
subjected toWestern blot analysis in NuPAGE 4–12% Bis–Tris gradient
minigels (Invitrogen). For normalization, total cell lysate was loaded
simultaneously and the level of surface expression of hSMVT was
determined using a speciﬁc antibody followed by an HRP tagged
secondary antibody. The band intensity of biotinylated hSMVT was
normalized with total cellular hSMVT expression.
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The live cell imaging was performed by an inverted phase-contrast
confocal microscope (Nikon-C1) by growing Caco-2 cells on glass
bottomed petri-dishes (MatTek Corp., Ashland, MA). The cells were
excited using the 488 nm wavelength from an argon ion-laser, and
emission was measured by a 530±20-nm band-pass ﬁlter.
2.9. Statistical analysis
The uptake data shown here are the mean±SE of at least three
independent experiments and are expressed in terms of fmol per
milligram protein per 10 min. The signiﬁcance level was determined
by the Student's t-test, and p value of b0.05 was considered as being
signiﬁcant. Carrier-mediated uptake of 3H-biotin was determined by
subtracting the diffusion component (uptake in the presence of 1 mM
biotin) from total uptake. For the kinetic study, the diffusion
component was determined by multiplying biotin concentration byFig. 1. hSMVT protein is glycosylated, and glycosylation is important for function. A: Predicte
have 12 TMD [11,13]. The protein is also predicted to have four putative N-glycosylation m
(Ser283 and Thr286). B: Effect of tunicamycin on carrier-mediated biotin uptake by ARPE19 c
for 48 h) biotin uptake was assayed in KR buffer (pH 7.4). Control cells were transfected wi
*pb0.01. Inset: Western blot showing a shift in the molecular mass of hSMVT-GFP upon tu
tunicamycin (2 μg/ml for 48 h) and total protein was isolated as described in “Materials an
gradient mini gels and subjected to Western blot analysis using anti-GFP monoclonal antibod
is a representative of three independent experiments.the slope of the line between uptake at high biotin concentration
(1 mM) and the point of origin. The apparent Km and Vmax were
determined by applying the Michaelis–Menten equation via using
Graph Pad Prism software (Version 5.03). Western blotting, confocal
imaging and PCR analysis were all performed on three separate
occasions.
3. Results
As mentioned earlier, hydrophobicity analysis predicts the hSMVT
polypeptide to have 12TMD (Fig. 1A) [11,13]. In addition, analysis of the
amino acid sequence of hSMVT suggests that the polypeptide has four
potential N-glycosylation sites (at position Asn138, Asn489, Asn498, and
Asn534) and two potential PKC-phosphorylation sites (at position Ser283
and Thr286) (Fig. 1A) [11,13]. The potential N-glycosylation at Asn138 is
unique to hSMVT, while the other three potential N-glycosylation sites
are conserved across species (human, mouse, rat and rabbit). It is also
predicted that the potential N-glycosylation site at Asn138 is located ind membrane topology of hSMVT. Theoretical prediction suggests the hSMVT protein to
otifs (Asn138, Asn489 Asn498 and Asn534) and two potential PKC-phosphorylation sites
ells transiently expressing hSMVT. Following pre-treatment with tunicamycin (2 μg/ml
th empty pcDNA3.1(−) vector. Data are mean±SE of three independent experiments.
nicamycin pre-treatment. Transiently expressing ARPE19 cells were pre-treated with
d methods”. Equal amount of protein (30 μg) was resolved in NuPAGE 4–12% Bis–Tris
y. As a control, the same blot was probed with anti-β-actin antibody. The image shown
Fig. 2. Effect of mutating potential N-glycosylation sites on hSMVT functionality.
Carrier-mediated biotin uptake by cells expressing wild-type and mutated hSMVT.
ARPE19 cells were transiently transfected with 3 μg of wild-type or mutated hSMVT
and biotin uptake was assayed 48 h post transfection. Control (mock) ARPE19 cells
were transiently transfected with empty pcDNA 3.1 (−) vector. Data are mean±SE of
at least three independent experiments. *pb0.01.
Table 2
Kinetic parameters of the biotin uptake process in ARPE19 cells expressing wild-type
and mutated hSMVT.
Km (μM) Vmax (fmol/mg protein/10 min)
hSMVT 18.91±3.7 967.6±68.69
hSMVT (N138A) 17.61±2.56 84.53±4.29 (pb0.01)⁎
hSMVT (N489A) 10.26±4.76 202±27.2 (pb0.01)⁎
hSMVT (N138A, N489A) 20.13±3.57 74.63±4.85 (pb0.01)⁎
Kinetic parameters of the carrier-mediated biotin uptake by ARPE19 cells expressing
the wild-type hSMVT and the mutants.
⁎ p values were determined by Student-t test.
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hSMVT polypeptide, whereas Asn489 and Asn498 are both located in
the extracellular sequence between the eleventh and twelfth TMD. The
other predicted N-glycosylation site, Asn534, falls within the twelfth
TMD (Fig. 1A). With regards to the two potential PKC-phosphorylation
sites, both of these sites are predicted to be located in the intracellular
loop between the sixth and seventh TMD of the hSMVT polypeptide
(Fig. 1A). In addition,while the Ser283 is conserved across species, Thr286
is conserved in human and rabbit but replaced by Ser in mouse and rat.3.1. Glycosylation status of the hSMVT protein and role in
hSMVT function
3.1.1. The hSMVT protein is glycosylated
Previous immunological studies have demonstrated that the
hSMVT polypeptide has a higher molecular mass than what is pre-
dicted from its molecular mass [14,18,21]. This suggests that the
protein is subjected to a post-translational modiﬁcation(s). In this
study, we aimed at testing whether the hSMVT protein is glyco-
sylated, and if so, to determine the effect of this glycosylation on its
function. Thus, we pre-treated ARPE19 cells that are transiently
expressing hSMVT-GFP with the glycosylation inhibitor tunicamycinFig. 3. Kinetic parameters of carrier-mediated biotin uptake by ARPE19 cells transiently
expressing the wild-type and mutated hSMVT. ARPE19 cells were transfected with an
equal amount (3 μg) of plasmids and uptake was measured at 48 h of transfection. Data
are mean±SE of three independent experiments; when not shown, the SE is smaller
than the symbol.(2 μg/ml for 48 h) then performed Western blot analysis on cellular
protein (ARPE19 cells were chosen in these studies because they
express hSMVT efﬁciently and were previously used for such
investigations [13,18]). The result showed a clear shift in the
molecular size of the speciﬁc hSMVT band in cells treated with
tunicamycin that were compared to control (untreated) cells
(Fig. 1B inset). A similar shift in the molecular size of hSMVT was
observed on the Western blot when the total protein isolated from
the hSMVT-GFP expressing cells was treated with N-glycosidase F
(PNGaseF) (data not shown). These results clearly suggest that the
hSMVT polypeptide is glycosylated.
To examine the effect of this glycosylation on the function of hSMVT,
we examined the effect of tunicamycin pre-treatment (2 μg/ml for 48 h)Fig. 4. Effect of mutating Asn138 and Asn489 of the hSMVT protein on level of expression.
A: Effect on mRNA expression: real-time PCR was performed using total RNA isolated
from ARPE19 cells transiently expressing wild-type or mutated hSMVT. Level of
expression of hSMVT was normalized relative to β-actin as described in “Materials and
methods”. Data are mean±SE of three independent experiments. B: Effect on protein
expression: ARPE19 cells were transiently transfected with wild-type or mutated
hSMVT-GFP constructs and total protein was isolated 48 h post transfection and used
for Western blotting. The blot was probed with anti-GFP antibody and expression was
normalized relative to β-actin. The graphical representation shows the relative
expression of the mutated hSMVT after normalization. *pb0.01 and **pb0.05. The
inset shows a representative Western blot image.
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a signiﬁcant (pb0.01) reduction in carrier-mediated biotin (9 nM)
uptake in tunicamycinpre-treated cells compared to control (untreated)
cells (Fig. 1B).
3.1.2. Effect of mutating the individual potential N-glycosylation sites on
hSMVT function
To determine which of the four potential N-glycosylation sites
of the hSMVT polypeptide plays a role in the function of the
protein in transporting biotin, we mutated these sites individually
(to alanine) and examined the effect that mutation on functionality
of hSMVT following transient expression in ARPE19 cells. TheFig. 5. Effect of pre-treatment with phorbol 12-myristate 13-acetate (PMA) on hSMVT
functionality and expression. A: Effect on biotin uptake: ARPE19 cells transiently
expressing hSMVT were pre-treated with 10 μM of PMA (or its negative control 4α-
PMA) for 1 h, followed by determination of carrier-mediated biotin uptake as described
in “Materials and methods”. Data are mean±SE of three independent experiments.
*pb0.01. B: Effect on total cellular hSMVT protein expression: total protein was isolated
from ARPE19 cells transiently expressing hSMVT-GFP and pre-treated with PMA.
Western blot analysis was performed using anti-hSMVT antibody as described in
“Materials and methods”. Expression was normalized relative to β-actin and data
shown are mean±SE of three experiments. Inset shows a representative Western blot
image. C: Effect of PMA pre-treatment on membrane expression of hSMVT.
Biotinylation of cell surface protein of transiently transfected ARPE19 cells was
performed as described in “Materials and methods”. An equal amount (3 μg) of wild-
type hSMVT construct was transfected into ARPE19 cells and 48 h after transfection
cells were treated for 1 h with PMA. Level of biotinylated membranous hSMVT was
normalized relative to total hSMVT. Data are mean±SE of three independent
experiments. Inset: Representative Western blot image from the same blot (adjacent
lanes) showing the level of membrane expression of wild-type hSMVT on PMA
treatment.results showed that while mutating Asn138 and Asn489 lead to a
signiﬁcant (pb0.01 for both) decrease in carrier-mediated biotin
uptake, mutating Asn498 and Asn534 resulted in no effect (Fig. 2).
We also introduced double mutations (at Asn138 and Asn489) in the
hSMVT protein and observed even further reduction in biotin
uptake.
3.1.3. Effect of mutating Asn138 and Asn489 of the hSMVT protein on
kinetic parameters of biotin uptake
The effect of mutating Asn138 or Asn489 of hSMVT individually
or together on kinetic parameters (apparent Km and Vmax) of the
biotin uptake process of ARPE19 cells expressing these mutants
was examined and the data was compared to uptake kinetic
parameter of cells expressing the wild-type hSMVT. The results
showed a signiﬁcant (pb0.01 for all) reduction in the Vmax of the
biotin uptake process by all mutants with no effect on the apparent
Km (Fig. 3 and Table 2). The decrease in Vmax, but not apparent Km
of the biotin uptake process suggests that the observed loss in
hSMVT functionality is mediated via a decrease in the number
(and/or activity) of the functional carriers with no change in their
afﬁnity.
3.1.4. Effect of Asn138 and Asn489 mutations on level of hSMVT mRNA
and protein expression
To determine whether mutating the Asn138 and Asn489 sites of
hSMVT affected the transport via affecting the mRNA expression,Fig. 6. Effect of mutating Ser283 and Thr286 on the level of expression of hSMVT. A: Effect
on the level of mRNA expression: total RNAwas isolated 48 h post transfection and real-
time PCR was performed using speciﬁc primer against hSMVT. Data (normalized
relative to β-actin) are mean±SE of three independent experiments. B: Effect on the
level of protein expression: Western blot analysis was performed using 50 μg of total
protein isolated from transiently transfected ARPE19 cells. The speciﬁc band for hSMVT
was detected using anti-hSMVT polyclonal antibodies and the level of expression was
normalized relative to β-actin. Data are mean±SE of three experiments. Inset depicts
representative Western blot image.
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different hSMVT mutants as well as that of the wild-type protein
after simultaneous transfection of equal amounts (3 μg) of cDNA
into ARPE19 cells. Data was normalized relative to β-actin. The
results showed no signiﬁcant difference in the level of mRNA
expression between the two mutants to that of wild-type hSMVT
(Fig. 4A). We also examined the effect of mutating Asn138 or
Asn489 residues on the level of hSMVT protein expression. In this
study, we again transfected ARPE19 cells with equal amounts of
wild-type or mutated hSMVT-GFP constructs (3 μg), then we
extracted total protein and subjected the extract to Western blot
analysis using monoclonal anti-GFP antibody; the level of β-actin
was also determined as internal control (Fig. 4B, inset). The results
showed that mutating Asn138 leads to an approximately 20 fold
reduction in the level of expression of the hSMVT protein
(pb0.01), while mutating Asn489 leads to a reduction of 1.2 fold
(pb0.05) compared to wild-type hSMVT (Fig. 4B inset).
3.2. Role of the potential PKC-phosphorylation sites of the hSMVT protein
in mediating the PMA-induced inhibition in biotin uptake
Previous studies have suggested the involvement of a PKC-mediated
pathway in the regulation of intestinal biotin uptake [16,17]. Stimulat-Fig. 7.Membrane expression of the Ser283 and Thr286 hSMVT mutants. A: Biotinylation assay
mutant (S283A and T286A) hSMVT-GFP constructs 48 h post transfection. Western blottin
expression was normalized relative to the total amount of cellular hSMVT (see “Materials an
Western blot image of biotinylated and total hSMVT protein. B: Confocal imaging: cellular d
transiently expressing an equal amount of wild-type or mutant hSMVT (4 μg). Imaging waing PKCwith phorbol 12-myristate 13-acetate (PMA)was found to lead
to signiﬁcant inhibition in biotin uptake, an effect thatwasmediated via
changes in the Vmax (but not the apparent Km) of the biotin uptake
process [17]. The latter observation suggested that the PMA (PKC) effect
is mediated via changes in the activity (and/or number) of the biotin
transport carriers (i.e., hSMVT) with no change in their afﬁnity. The
cellular and molecular mechanism(s) involved in this regulation,
however, was not investigated and was therefore addressed in this
study.3.2.1. Effect of PMA pre-treatment on level of expression of hSMVT mRNA
and protein, and on membrane expression
In these studies, we ﬁrst conﬁrmed that PMA (but not its negative
control 4α PMA) pre-treatment (10 μM for 1 h) inhibits biotin (9 nM)
uptake by ARPE19 cells expressing hSMVT (Fig. 5A). We then asked if
this inhibition is due to reduction in the level of expression of the
hSMVTmRNA and/or protein using quantitative PCR andWestern blot
analysis, respectively. Quantitative PCR data showed that PMA pre-
treatment does not show any effect on the level of hSMVT mRNA
expression (Data not shown). Western blotting using total protein
also showed no change in hSMVT expression on PMA pre-treatment
(Fig. 5B).: biotinylation was performed on ARPE19 cells transiently expressing the wild-type and
g was performed using anti-GFP monoclonal antibody and the level of membranous
d methods”). Data are mean±SE of hSMVTmembrane expression. Inset: representative
istribution of hSMVT-GFP along the lateral (xy) and axial (xz) sections of Caco-2 cells
s performed 48 h post transfection.
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internalization of the carrier (i.e., removal from cell membrane)
[10,22,23], we investigated whether this possibility also applies in the
case of PMA inhibition of biotin uptake. This was performed using
biotinylation assay (see “Materials and methods”). The results
showed no change in the intensity of the biotinylated hSMVT
(normalized relative to total cellular hSMVT) in PMA-pre-treated
and control (untreated) cells (Fig. 5C), suggesting equal membrane
expression of the protein.
Collectively, the above ﬁndings suggest that the inhibitory effect of
PMA (PKCmodulator) on biotin uptake is not mediated via alterations
in the level of expression of hSMVT protein ormRNA, nor in its level of
expression at the cell membrane.3.2.2. Role of the potential PKC phosphorylation sites (Ser283 and Thr286)
of the hSMVT polypeptide in mediating the PMA-induced inhibition of
biotin uptake
As mentioned earlier, the hSMVT polypeptide is predicted to have
two potential PKC phosphorylation sites, one being Ser283 and the
other Thr286 (Fig. 1A). To determine if these sites are important in
mediating the PMA-induced inhibition in biotin uptake, we mutated
these sites (to alanine) then examined the effect of this mutation on
PMA-induced inhibition in the vitamin uptake. Since mutating a given
amino acid of a transporter protein could lead to changes in the level
of expression of its mRNA and/or protein as well as in its level of
expression at the cell surface, we tested these possibilities ﬁrst by
means of quantitative PCR, Western blotting and membrane biotiny-
lation assay/confocal imaging, respectively. Our quantitative PCR data
showed no change in the level of hSMVT mRNA expression as a result
of mutating Ser283 and Thr286 (Fig. 6A). Similarly, Western blot
analysis using total protein from ARPE19 cells expressing equal
amounts of wild-type or mutated (Ser283 and Thr286) hSMVT showed
no change in the level of expression of the protein (Fig. 6B). Finally,
mutating Ser283 and Thr286 of the hSMVT protein did not affect its
surface expression as indicated by results of biotinylation and by
confocal imaging methods (Fig. 7A and B).Fig. 8. Effect of mutating the potential PKC phosphorylation sites (Ser283 and Thr286) of h
transfected with an equal amount (3 μg) of wild-type or mutated (S283A and T286A) hSMVT
(10 μM for 1 h) and untreated cells. Data shown is the mean±SE of the three independent e
**pb0.01. The comparison was made relative to the appropriate untreated control construc
respect to untreated set and relative percentage was plotted as percentage. **pb0.01.After establishing that mutating Ser283 and Thr286 of the hSMVT
polypeptide does not affect the protein cellular and membrane
expression, we examined the effect of these mutations on the PMA-
induced inhibition in biotin uptake. For this, identical amounts (3 μg)
of wild-type and mutated (at Ser283 and Thr286) hSMVT were
transfected into ARPE19 cells followed by pre-treatment with PMA
(10 μM for 1 h) and examination of biotin (9 nM) uptake; data was
compared to untreated controls. The results showed that mutating
Thr286 leads to a disappearance in the PMA-induced inhibition in
biotin uptake; while mutating Ser283 had no effect on PMA-induced
inhibition in the vitamin uptake (Fig. 8). These ﬁndings suggest the
involvement of Thr286 (but not Ser283) in the PMA (PKC)-induced
inhibition in biotin uptake.4. Discussion
The aim of this study was to investigate the role of the putative N-
glycosylation and PKC-phosphorylation sites of the hSMVT polypep-
tide in the function and regulation of the carrier protein. The hSMVT
system is the major biotin uptake system in intestinal epithelial cells
[15]. The calculated molecular mass of the hSMVT protein (based on
its primary amino acid sequence) was found to disagree with its
observed molecular mass on Western blotting [14,18,21]. Whether
this is due to glycosylation of the predicted N-glycosylation sites is not
clear and was investigated in this study using different physiological
and molecular approaches. Our investigations using tunicamycin (a
nucleoside antibiotic that inhibits N-glycosylation) show a shift in the
molecular weight of hSMVT on Western blot to a level that is in
agreement with the theoretical prediction. Similar shifting in the
molecular weight of hSMVT on Western blot was observed when
treatment with PNGaseF was employed. These ﬁndings suggest that
hSMVT is glycosylated and this glycosylation is the main post-
translation modiﬁcation affecting the mature hSMVT protein. The N-
glycosylation of hSMVT that appeared to be important for its function
as pre-treatment of hSMVT-expressing cells with tunicamycin led to a
signiﬁcant inhibition in carrier-mediated biotin uptake.SMVT on the PMA-induced inhibition in biotin uptake. ARPE19 cells were transiently
. Carrier-mediated biotin uptake was then examined simultaneously in PMA pre-treated
xperiments of biotin uptake by untreated and PMA treated cells, respectively. *pb0.05,
t as indicated in the ﬁgure. Inset: uptake of the PMA treated cells was compared with
2080 A. Ghosal et al. / Biochimica et Biophysica Acta 1808 (2011) 2073–2080We also determined which of the four N-glycosylation sites
(Asn138, Asn489, Asn498, Asn534) of the hSMVT polypeptide is (are)
important for its function. This was performed by examining the
effect of mutating these sites individually on the functionality of
hSMVT expressed in ARPE19 cells. The results showed that mutating
Asn138 and Asn489 (but not Asn489 and Asn534) led to a signiﬁcant
reduction in biotin uptake, demonstrating the importance of these
sites in hSMVT functionality. Analysis of the kinetic parameters of
the biotin uptake process of cells expressing Asn138 and Asn489
hSMVT mutants showed a signiﬁcant reduction in the Vmax, but not
the apparent Km, of the biotin uptake process. This suggests
reduction in the number and/or activity, but not afﬁnity, of the
carrier system.
The effect of mutating the Asn138 and Asn489 of the hSMVT protein
on biotin uptake was not mediated via changes in the level of
expression of the hSMVT mRNA as a similar level of expression was
found between the mutants and the wild-type hSMVT. However,
mutating these sites, while leading to a shift in protein size, also led to
a signiﬁcant decrease in the level of expression of the hSMVT protein.
These ﬁndings suggest that these sites are important for glycosylation
and for normal protein abundance.
We also investigated the role of the two putative PKC-
phosphorylation sites of the hSMVT polypeptide in the previously
observed PKC-mediated regulation of biotin uptake [16,17,24].
Using ARPE19 cells expressing hSMVT [where PMA (but not its
negative control 4α PMA) inhibits biotin uptake], we found the
PMA inhibition not to be mediated via an effect on the level of
expression of the hSMVT mRNA or total cellular level of the
transport protein. It was also not mediated by an effect on the
level of expression of hSMVT at the cell membrane, thus excluding
the possibility that the effect is mediated via removal of the
protein from cell the surface [22–24]. Based on these ﬁndings, it is
reasonable to suggest that the PMA (PKC)-induced inhibition in
biotin uptake is likely to be mediated by an effect on the activity of
the hSMVT system itself. We next examined the role of the
potential PKC phosphorylation sites (Ser283 and Thr286) of hSMVT
in mediating the PMA-induced inhibition in biotin uptake. This was
performed by examining the effect of mutating these sites
individually on the PMA-induced inhibition on biotin uptake.
Because mutating a given residue in a protein could affect that
protein level of expression and/or stability, we addressed these
issues ﬁrst. This was achieved by means of quantitative PCR,
Western blotting and membrane biotinylation assays/confocal
imaging studies, which showed that such mutations do not affect
the expression or stability of hSMVT. Our studies on the effect of
mutating Ser283 and Thr286 of hSMVT on the PMA-induced
inhibition in biotin uptake showed that mutating the latter, but
not the former, residue led to a disappearance in the PMA-induced
inhibition in the vitamin uptake. These ﬁndings suggest that Thr286
is involved in mediating the PMA (PKC)-induced inhibition in
biotin uptake.
In conclusion, our studies demonstrate that the hSMVT protein is
glycosylated and this glycosylation is important for function. Also,
the predicted PKC phosphorylation site Thr286 (but not Ser283)
appears to be involved in mediating the PKC-induced regulation of
biotin uptake.Acknowledgements
This work was supported by grants from the Department of
Veterans Affairs and the National Institutes of Health (DK58057
and DK56061).
References
[1] R.J. McMahon, Biotin in metabolism and molecular biology, Annu. Rev. Nutr. 22
(2002) 221–239.
[2] B. Wolf, The metabolic and molecular basis of inherited disease, in: C.R. Scriver, A.
Beaudet (Eds.), McGraw-Hill, New York, NY, 2001, pp. 3935–3962.
[3] B.B. Bowman, I.H. Rosenberg, Biotin absorption by distal rat intestine, J. Nutr. 117
(1987) 2121–2126.
[4] O.M. Wrong, C.J. Edmonds, V.S. Chadwich, Vitamins, The Large Intestine: Its Role
In Mammalian Nutrition and Homeostasis, Wiley and Sons, New York, 1981,
pp. 157–166.
[5] M.F. Sorrell, O. Frank, A.D. Thomson, A. Aquino, H. Barker, Absorption of vitamins
from large intestine, Nutr. Res. Int. 3 (1971) 143–148.
[6] H. Kasper, Vitamin absorption in the colon, Am. J. Proctol. 21 (1970) 341–345.
[7] C.A. Barth, M. Frigg, H. Hogemeister, Biotin absorption from the hindgut of the pig,
J. Anim. Physiol. Anim. Nutr. 55 (1986) 128–134.
[8] H.M. Said, Recent advances in carrier-mediated intestinal absorption of water
soluble vitamins, Annu. Rev. Physiol. 66 (2004) 419–446.
[9] H.M. Said, B. Seetharam, Physiology of the gastrointestinal tract, in: L.R. Johnson
(Ed.), Academic Press, San Diego, 2006, pp. 1791–1825.
[10] J.C. Reidling, V.S. Subramanian, T. Dahhan, M. Sadat, H.M. Said, Mechanisms and
regulation of vitamin C uptake: studies of the hSVCT systems in human liver
epithelial cells, Am. J. Physiol. Gastrointest. Liver Physiol. 295 (2008) G1217–G1227.
[11] H. Wang, W. Huang, Y.J. Fei, H. Xia, T.L. Yang-Feng, F.H. Leibach, L.D. Devoe, V.
Ganapathy, P.D. Prasad, Human placentral Na+-dependent multivitamin
transporter. Cloning, functional expression, gene structure, and chromosomal
localization, J. Biol. Chem. 274 (1999) 14875–14883.
[12] N.S. Chatterjee, C.K. Kumar, A. Ortiz, S.A. Rubin, H.M. Said, Molecular mechanism
of the intestinal biotin transport process, Am. J. Physiol. 277 (1999) C605–C613.
[13] P.D. Prasad, H. Wang, W. Huang, Y.J. Fei, F.H. Leibach, L.D. Devoe, V. Ganapathy,
Molecular and functional characterization of the intestinal Na+-dependent
multivitamin transporter, Arch. Biochem. Biophys. 366 (1999) 95–106.
[14] V.S. Subramanian, J.S. Marchant, M.J. Boulware, T.Y. Ma, H.M. Said, Membrane
targeting and intracellular trafﬁcking of the human sodium-dependent multivi-
tamin transporter in polarized epithelial cells, Am. J. Physiol. Cell Physiol. 296
(2009) C663–C671.
[15] K. Balamurugan, A. Ortiz, H.M. Said, Biotin uptake by human intestinal and liver
epithelial cells: role of the SMVT system, Am. J. Physiol. Gastrointest. Liver Physiol.
285 (2003) G73–G77.
[16] H.M. Said, Cellular uptake of biotin: mechanisms and regulation, J. Nutr. 129
(1999) 490S–493S.
[17] H.M. Said, A. Ortiz, E. McCloud, D. Dyer, M.P. Moyer, S. Rubin, Biotin uptake by
human colonic epithelial NCM460 cells: a carrier-mediated process shared with
pantothenic acid, Am. J. Physiol. 275 (1998) C1365–C1371.
[18] A. Ghosal, H.M. Said, Structure–function activity of the human sodium-dependent
multivitamin transporter: role of His(115) and His(254), Am. J. Physiol. Cell
Physiol. 300 (2010) C97–C104.
[19] J.C. Reidling, S.M. Nabokina, H.M. Said, Molecular mechanisms involved in the
adaptive regulation of human intestinal biotin uptake: a study of the hSMVt
system, Am. J. Physiol. Gastrointest. Liver Physiol. 292 (2007) G275–G281.
[20] K.J. Livak, T.D. Schmittgen, Analysis of the relative gene expression data using real-
time quantative PCR and the 2(−delta delta C(T)) method, Methods 25 (2001)
402–408.
[21] S.M. Nabokina, V.S. Subramanian, H.M. Said, Association of PDZ-containing protein
PDZ11 with human sodium dependent multivitamin transporter, hSMVT, Am. J.
Physiol. Gastrointest. Liver Physiol. (December 23 2010), doi:10.1152/ajpgi.00530.
[22] A. Rotmann, D. Strand, U.Martine, E.I. Closs, Protein kinase C activation promotes the
internalization of the human cationic amino acid transporter hCAT-1. A new
regulatory mechanism for hCAT-1 activity, J. Biol. Chem. 279 (2004) 54185–54192.
[23] V. Padovano, S. Massari, S. Mazzucchelli, G. Pietrini, PKC induces internalization
and retention of the EAAC1 glutamate transporter in recycling endosomes of
MDCK cells, Am. J. Physiol. Cell Physiol. 297 (2009) C835–C844.
[24] T.Y. Ma, D.L. Dyer, H.M. Said, Human intestinal cell line Caco-2: a useful model for
studying cellular and molecular regulation of biotin uptake, Biochim. Biophys.
Acta 1189 (1994) 81–88.
